TPG Inc. has announced its financial results for the third quarter of 2026, highlighting significant achievements and a positive outlook for the future. The company reported strong momentum across its operations, with CEO Jon Winkelried emphasizing the firm’s ability to exceed its fundraising target of $50 billion this year.
On October 29, 2026, TPG released a summary press release and a detailed earnings presentation, which are available on its Investor Relations website. The report indicates that TPG raised $15 billion in the quarter, bringing its year-to-date total to nearly $42 billion. This impressive fundraising effort is supported by a record $86 billion in available capital, positioning TPG to capitalize on upcoming investment opportunities.
Winkelried stated, “TPG delivered an exceptional third quarter, reflecting broad-based momentum across the firm and continued progress across each of our strategic objectives.” This optimism is echoed in the company’s declaration of a quarterly dividend of $0.55 per share, payable on November 23, 2026, to shareholders of record by November 9, 2026.
TPG Inc., incorporated in Delaware, operates in the investment advice sector (SIC: 6282) and is listed on the Nasdaq under the ticker symbols TPG and TPGXL. The company has a long-standing reputation as a leading global alternative asset management firm, managing approximately $346 billion in assets.
The filing indicates that TPG’s strategic focus and investment performance have positioned it well for future growth. As the investment advice industry evolves, TPG’s recent successes may inspire increased competition among peers. The filing does not specify what actions will follow this announcement, but the company’s upcoming conference call is expected to provide further insights into its performance and future strategies.
Read Next
IPG Photonics reports strong Q3 results with revenue growth
BETA Technologies Reports Record Revenue for Q3 2026
Angel Oak Mortgage REIT reports Q3 2026 financial results
Energy Transfer LP Reports Strong Q3 2026 Financial Results
Faeth Therapeutics Reports Q3 2026 Financial Results
Enpro reports strong Q3 results, raises full-year guidance




